CD274 and neoplasm: A study proved that treatment with Nr-CWS could reduce Programmed cell death 1 ligand 1 (PD-L1) in tumor tissues and provide the possibility for the combination of Nr-CWS with PD-1/PD-L1 antibodies [43].